新型蛋白质降解治疗剂的分子设计 目前正在临床试验中
Ela Kacin1, Raj Nayan Sewduth1
1VIB-KU Leuven Center for Cancer Biology (VIB), 3000 Leuven, Belgium.
Pharmaceutics
|June 27, 2025
概括
临床试验正在推进蛋白质降解疗法,如蛋白质溶解向金马 (PROTACs),以向以前无法治疗的蛋白质,用于包括癌症和自身免疫性疾病在内的疾病.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 蛋白质调制是治疗开发中的一个关键领域.
- 像蛋白质溶解向金马 (PROTACs) 这样的创新技术提供了向蛋白质的新方法.
- 许多疾病涉及的蛋白质以前被认为是不可抗药的.
研究的目的:
- 审查目前专注于蛋白质降解的临床试验的现状.
- 突出这些新方法的治疗潜力和挑战.
- 讨论对各种疾病领域的影响,包括瘤学,自身免疫和神经系统疾病.
主要方法:
- 审查正在进行和已完成的使用蛋白质降解策略的临床试验.
- 专注于诸如PROTAC和其他蛋白质降解剂等技术.
- 治疗目标和疾病征兆的分析.
主要成果:
- 在针对特定蛋白质的治疗效益方面有前途的进展.
- 例如包括ARV-471用于乳腺癌和ARV-110用于前列腺癌.
- 早期的试验显示了向多发性骨髓瘤中的IKZF1/3和自身免疫性疾病中的IRAK4的潜力.
结论:
- 蛋白质降解疗法在治疗复杂疾病方面显示出显著的前景.
- 需要解决生物可用性,稳定性和输送方面的挑战.
- 这些试验有可能彻底改变治疗模式,并为患者提供希望.
相关概念视频
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Regulated Protein Degradation
2.6K
2.6K
Microorganisms in Medicine and Therapeutics
360
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
360


